checkAd

    BBS-Bioactive Bone Substitutes Plc  148  0 Kommentare INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM) - Seite 2

    A share issue may be executed by increasing a share capital by a new subscription, by convertible bonds or by issuing stock options in one or more installments under the following terms:

    The Board is authorised to decide to increase the share capital by issuing a share issue, issuing a convertible loan, or issuing stock options in one or more installments. In the new issue or alternatively, convertible loans or stock options may entitle to subscribe for a maximum of 2.000.000 ( two million) new shares. The company currently has 6.571.525 shares. The old authorisation is proposed to be cancelled.

    The authorisation includes the right to deviate from the shareholders’ pre-emptitive right to subscribe for new shares, convertible loans or warrants and to decide on the subscription prices, subscription rights and subscription terms. The subscription price of the shares is recorded in the invested unrestricted equity fund. The authorisation may be used in deviation from shareholder’s pre-emptitive subscription right, provided that there is a significant financial reason for the company, such as the extension of the company’s shareholder base or another essential business interest or an arrangement to safeguard financial liquidity. Under the authorization, shares may be offered in deviation from shareholder’s pre-emptive rights to the related party but not for the benefit of related parties. The Board is entitled to decide that shares can be subscribed for against payment of assets, by using the right of set-off or otherwise on specific terms. Possible options are used at the discretion of the Board.

    The authorisation is valid until the next AGM but up to June 30th 2022.

    16)  Closing of the meeting

    B. AGM DOCUMENTS

    The financial statements and the auditor’s report are available to shareholders at the company’s premises at Kiviharjunlenkki 6, 90220 Oulu and on Company’s website at //www.bbs-artebone.fi/ Copies of the documents will be sent to shareholders on request.

    C: INSTRUCTIONS FOR THE PARTICIPANTS IN THE MEETING

    1. Shareholders listed in the shareholder register
    The right to attend the AGM will be on each shareholder who, on the record date of April 14th 2021 of the AGM, is registered in the company’s shareholder register maintained by Euroclear Finland Oy. A shareholder whose shares are subscribed to his or her personal Finnish book-entry account is registered in the company’s shareholder register.

    Seite 2 von 4



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    BBS-Bioactive Bone Substitutes Plc INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM) - Seite 2 Stock Exchange Release April 7th, 2021 at 6.00 pm INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM) The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s Annual General Meeting, which …